New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Ligand Pharmaceuticals Incorporated
LGND
Shape
US Flag

NASDAQ

2B

Biotechnology

Next Earning date - 25 Feb 2025

2B

Biotechnology

Next Earning date - 25 Feb 2025

105.36USD
Shape-0.93 ( -0.87%)
favorite-chart

Relative Strenght

83
favorite-chart

Volume Buzz

-88%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

19%

Quote Panel

Shape
Updated January 13, 2025
1W -3.65 % 1M -13.13 % 3M 2.73 % 1Y 49.54 %

Key Metrics

Shape
  • Market Cap

    2.01B


  • Shares Outstanding

    18.90M


  • Share in Float

    18.48M


  • Dividende

    0


  • Earning Date

    25 Feb 2025


  • Price Target

    106.28


  • Average Volume

    123878


  • Beta

    0.896


  • Range

    67.53-129.9


  • Industry

    Biotechnology


  • Website

    https://www.ligand.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

LGND

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$187M

Shape261%

2025-Revenue

$6.07

Shape1655%

2025-EPS

$83M

Shape2542%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

157.00(49.02%)

Number of analyst

1

Last analyst upgrade/downgrade

Oppenheimer

initialise

Previous: Not converted

2024-10-02

Now: Outperform

RBC Capital

initialise

Previous: Not converted

2024-07-30

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-24%

1.36
vs 1.8

Q1.23

arrow
arrow

+293%

2.28
vs 0.58

Q2.23

arrow
arrow

+318%

1.42
vs 0.34

Q3.23

arrow
arrow

+149%

1.02
vs 0.41

Q4.23

arrow
arrow

-23%

1.05
vs 1.36

Q1.24

arrow
arrow

-47%

1.2
vs 2.28

Q2.24

arrow
arrow

-1%

1.4
vs 1.42

Q3.24

arrow
arrow

N/A

-0.39
vs 1.02

Q4.24

arrow
arrow

+13%

1.19
vs 1.05

Q1.25

arrow
arrow

+4%

1.24
vs 1.2

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-30%

50.4M  vs 72.5M

Q1.23

arrow
arrow

-4%

44M  vs 45.7M

Q2.23

arrow
arrow

-54%

26.4M  vs 57.4M

Q3.23

arrow
arrow

-50%

32.9M  vs 66.1M

Q4.23

arrow
arrow

-44%

28.1M  vs 50.4M

Q1.24

arrow
arrow

-30%

31M  vs 44M

Q2.24

arrow
arrow

+58%

41.5M  vs 26.4M

Q3.24

arrow
arrow

+58%

51.8M  vs 32.9M

Q4.24

arrow
arrow

+39%

39M  vs 28.1M

Q1.25

arrow
arrow

+17%

36.3M  vs 31M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-2%

-0.02
vs 0

Q1.23

arrow
arrow

+6%

0.06
vs -0.02

Q2.23

arrow
arrow

+0%

0
vs 0.06

Q3.23

arrow
arrow

-2%

-0.02
vs 0

Q4.23

arrow
arrow

+3%

0.03
vs -0.02

Q1.24

arrow
arrow

+11%

0.11
vs 0.03

Q2.24

arrow
arrow

-7%

-0.07
vs 0.11

Q3.24

arrow
arrow

-1%

-0.01
vs -0.07

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

199

199
vs 203

-2%

Q1.23

arrow
arrow

213

213
vs 199

7%

Q2.23

arrow
arrow

206

206
vs 213

-3%

Q3.23

arrow
arrow

200

200
vs 206

-3%

Q4.23

arrow
arrow

217

217
vs 200

9%

Q1.24

arrow
arrow

227

227
vs 217

5%

Q2.24

arrow
arrow

236

236
vs 227

4%

Q3.24

arrow
arrow

246

246
vs 236

4%

Earnings Growth

Latest News